Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford BioMedica acquires anticancer macrophage technology

May 2, 1997

Emisphere receives notices of allowance for oral delivery technologies

April 28, 1997

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

April 28, 1997

Biosource awarded grant for human therapeutic protein production

April 25, 1997

Avigen granted patent on high-yield AAV production for gene therapy

April 24, 1997

Hybridon issued patent for pent-enoyl-protected nucleotides

April 23, 1997

Oncor's Sunrise Amplification Detection System presented

April 23, 1997

Genetronics develops electroporation therapy drug delivery system

April 23, 1997

AntiCancer receives grant for development of mouse cancer model

April 21, 1997

Ribozyme and Schering AG to collaborate on target validation and therapeutic development

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026